Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): Efficacy and safety in 42 patients

British Journal of Haematology

Volumn 116, Issue 3, 2002, Pages 619-624

  Preston, F E ^a   Laidlaw, S T ^a   Sampson, B ^a   Kitchen, S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Beriplex; Oral anticoagulation; Overanticoagulation; Prothrombin complex concentrates (PCC); Warfarin

Indexed keywords

ANTITHROMBIN; BERIPLEX; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; PROTEIN C; PROTHROMBIN; PROTHROMBIN COMPLEX; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART FAILURE; HEMOSTASIS; HUMAN; INTERNATIONAL STANDARD UNIT; KIDNEY FAILURE; LEG AMPUTATION; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; STROKE; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PLATELET COUNT; PROTEIN C; TREATMENT OUTCOME; WARFARIN;

EID: 0036183415     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1048.2001.03295.x     Document Type: Article

References (13)

1. Management of oral anticoagulant-induced intracranial haemorrhage
2. Measurement of activated factor IX in factor IX concentrate: Correlation with in-vivo thrombogenicity
3. Postoperative thromboses in hemophilia B
4. Thromboembolic complications - Task force report
5. Thrombogenicity of prothrombin complex concentrates
6. Comparison of different prothrombin complex concentrates: In-vitro and in-vivo studies
7. Thrombogenicity associated with factor IX complex concentrates
8. Emergency oral anticoagulant reversal; the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy
9. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation
10. Bleeding complications in oral anticoagulant therapy
11. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy
12. High purity factor IX and prothrombin complex concentrate (PCC): Pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC
13. The use of factor IX concentrates in man: A 9 year experience